LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Fluconazole 1 g  | ≥98%

LKT Laboratories, Inc.

Triazole; 14-α demethylase inhibitor.

More Information Supplier Page

×

Fluconazole

Fluconazole 5 g  | ≥98%

LKT Laboratories, Inc.

Triazole; 14-α demethylase inhibitor.

More Information Supplier Page

×

Fluconazole

Fludarabine 5 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine

Fludarabine 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine

Fludarabine 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine

Fludarabine Phosphate 5 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine Phosphate

Fludarabine Phosphate 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine Phosphate

Fludarabine Phosphate 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine Phosphate

Fludarabine Phosphate 100 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist.

More Information Supplier Page

×

Fludarabine Phosphate

Flufenamic Acid 10 g  | ≥97%

LKT Laboratories, Inc.

NSAID; TREK1 K+ potentiator, voltage-gated Na+ channel blocker, TRPC3 and TRPM2 antagonist, COX-1/2 inhibitor.

More Information Supplier Page

×

Flufenamic Acid

Flufenamic Acid 50 g  | ≥97%

LKT Laboratories, Inc.

NSAID; TREK1 K+ potentiator, voltage-gated Na+ channel blocker, TRPC3 and TRPM2 antagonist, COX-1/2 inhibitor.

More Information Supplier Page

×

Flufenamic Acid

FluM1 A2 Peptide (58-66) 1 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, influenza matrix protein M1 epitope.

More Information Supplier Page

×

FluM1 A2 Peptide (58-66)

FluM1 A2 Peptide (58-66) 2 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, influenza matrix protein M1 epitope.

More Information Supplier Page

×

FluM1 A2 Peptide (58-66)

FluM1 A2 Peptide (58-66) 5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, influenza matrix protein M1 epitope.

More Information Supplier Page

×

FluM1 A2 Peptide (58-66)

Flumazenil 25 mg  | ≥98%

LKT Laboratories, Inc.

GABA-A antagonist.

More Information Supplier Page

×

Flumazenil

Flumazenil 100 mg  | ≥98%

LKT Laboratories, Inc.

GABA-A antagonist.

More Information Supplier Page

×

Flumazenil

Flumequine Sodium 1 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor, GABA-A antagonist.

More Information Supplier Page

×

Flumequine Sodium

Flumequine Sodium 5 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor, GABA-A antagonist.

More Information Supplier Page

×

Flumequine Sodium

Flumequine Sodium 25 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor, GABA-A antagonist.

More Information Supplier Page

×

Flumequine Sodium

Fluocinolone Acetonide 25 mg  | ≥98%

LKT Laboratories, Inc.

Synthetic hydrocortisone derivative; glucocorticoid agonist.

More Information Supplier Page

×

Fluocinolone Acetonide

Fluocinolone Acetonide 100 mg  | ≥98%

LKT Laboratories, Inc.

Synthetic hydrocortisone derivative; glucocorticoid agonist.

More Information Supplier Page

×

Fluocinolone Acetonide

Fluocinolone Acetonide 250 mg  | ≥98%

LKT Laboratories, Inc.

Synthetic hydrocortisone derivative; glucocorticoid agonist.

More Information Supplier Page

×

Fluocinolone Acetonide

Fluocinolone Acetonide 1 g  | ≥98%

LKT Laboratories, Inc.

Synthetic hydrocortisone derivative; glucocorticoid agonist.

More Information Supplier Page

×

Fluocinolone Acetonide

Fluoxetine Hydrochloride 1 g  | ≥98%

LKT Laboratories, Inc.

FIASMA, SERT inhibitor, 5-HT and σ1 antagonist.

More Information Supplier Page

×

Fluoxetine Hydrochloride

Fluoxetine Hydrochloride 5 g  | ≥98%

LKT Laboratories, Inc.

FIASMA, SERT inhibitor, 5-HT and σ1 antagonist.

More Information Supplier Page

×

Fluoxetine Hydrochloride

Fluphenazine Hydrochloride 1 g  | ≥97%

LKT Laboratories, Inc.

Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker.

More Information Supplier Page

×

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride 5 g  | ≥97%

LKT Laboratories, Inc.

Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker.

More Information Supplier Page

×

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride 25 g  | ≥97%

LKT Laboratories, Inc.

Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker.

More Information Supplier Page

×

Fluphenazine Hydrochloride

Flupirtine Maleate 10 mg  | ≥98%

LKT Laboratories, Inc.

Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator.

More Information Supplier Page

×

Flupirtine Maleate

Flupirtine Maleate 25 mg  | ≥98%

LKT Laboratories, Inc.

Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator.

More Information Supplier Page

×

Flupirtine Maleate

Flupirtine Maleate 100 mg  | ≥98%

LKT Laboratories, Inc.

Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator.

More Information Supplier Page

×

Flupirtine Maleate

Flurbiprofen 1 g  | ≥98%

LKT Laboratories, Inc.

NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Flurbiprofen

Flurbiprofen 5 g  | ≥98%

LKT Laboratories, Inc.

NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Flurbiprofen

Flurbiprofen 25 g  | ≥98%

LKT Laboratories, Inc.

NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Flurbiprofen

Flutamide 1 g  | ≥98%

LKT Laboratories, Inc.

Non-steroid; AR antagonist.

More Information Supplier Page

×

Flutamide

Flutamide 5 g  | ≥98%

LKT Laboratories, Inc.

Non-steroid; AR antagonist.

More Information Supplier Page

×

Flutamide

Fluticasone Propionate 10 mg  | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

×

Fluticasone Propionate

Fluticasone Propionate 25 mg  | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

×

Fluticasone Propionate

Fluticasone Propionate 100 mg  | ≥98%

LKT Laboratories, Inc.

β2-adrenergic agonist.

More Information Supplier Page

×

Fluticasone Propionate

Flutriafol 500 mg  | ≥95%

LKT Laboratories, Inc.

Triazole; demethylation inhibitor, NMDA agonist.

More Information Supplier Page

×

Flutriafol

Flutriafol 5 g  | ≥95%

LKT Laboratories, Inc.

Triazole; demethylation inhibitor, NMDA agonist.

More Information Supplier Page

×

Flutriafol

Flutriafol 25 g  | ≥95%

LKT Laboratories, Inc.

Triazole; demethylation inhibitor, NMDA agonist.

More Information Supplier Page

×

Flutriafol

Fluvastatin Sodium 10 mg  | ≥98%

LKT Laboratories, Inc.

Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor.

More Information Supplier Page

×

Fluvastatin Sodium

Fluvastatin Sodium 50 mg  | ≥98%

LKT Laboratories, Inc.

Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor.

More Information Supplier Page

×

Fluvastatin Sodium

Fluvastatin Sodium 100 mg  | ≥98%

LKT Laboratories, Inc.

Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor.

More Information Supplier Page

×

Fluvastatin Sodium

Fluvoxamine Maleate 25 mg  | ≥97%

LKT Laboratories, Inc.

FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.

More Information Supplier Page

×

Fluvoxamine Maleate

Fluvoxamine Maleate 100 mg  | ≥97%

LKT Laboratories, Inc.

FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.

More Information Supplier Page

×

Fluvoxamine Maleate

Fluvoxamine Maleate 500 mg  | ≥97%

LKT Laboratories, Inc.

FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.

More Information Supplier Page

×

Fluvoxamine Maleate

Fmoc-Lys(Boc)-Leu-Lys(Boc) 1 g  | ≥98%

LKT Laboratories, Inc.

Tripeptide used for glycation.

More Information Supplier Page

×

Fmoc-Lys(Boc)-Leu-Lys(Boc)

FMRF 5 mg  | ≥95%

LKT Laboratories, Inc.

Neuropeptide, involved in reproductive behavior.

More Information Supplier Page

×

FMRF